NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Neurofenix

Neurofenix

Private
Naples, FloridaHealthcare & Life Scienceshttps://www.neurofenix.com/

Last Round

Series A

Aug 30, 2022

Total Funding Raised

$9.11M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Neurofenix is a digital health company that provides advanced virtual neurorehabilitation solutions for post-stroke and neurological patients through its at-home therapy platform and sensor-based devices.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Patient Engagement, Health IoT

Business Model

B2B2C

Customer Profile

Hardware + Subscription, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

neurorehabilitationstroke recoverydigital healthtelerehabgamified therapyremote patient monitoringRPMmedical devicephysical therapyvalue-based carehealth IoTrehab techwearable sensorsvirtual careat-home therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neurofenix Comparables

Compare Neurofenix with similar companies based on industry and business-model similarity.

Neurofenix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
IRegained
89%
Motus Nova
86%
GripAble
85%

Neurofenix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 30, 2022
SeedFeb 15, 2020
GrantSep 19, 2018
GrantMay 2, 2017
AcceleratorSep 6, 2016

Key People

Founding team and executive leadership

Dimitris Athanasiou

Co-founder CTO

Founding Team

Guillem Singla Buxarrais

Co-founder And Chief Executive Officer

Founding Team

Neurofenix Investors

Notable investors and investment history

Neurofenix investors
InvestorRounds
o2h venturesSeed, Series A
Inhealth VenturesSeries A
NestaGrant
Social Tech TrustSeed, Grant
Department for Business, Energy and Industrial StrategyGrant
Albion CapitalSeries A
Entrepreneurs FirstSeed, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors increased 79% MoM, reaching 4K.

  • May 15, 2026

    Monthly visitors increased 215% MoM, reaching 2.2K.

Neurofenix Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neurofenix Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neurofenix's valuation, stock price, and market status.

Firmographic Details

HeadquartersNaples, Florida
Employee Range7
Year Founded2016
Last FundingAug 30, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.